ENTITY
Genor Biopharma Holdings

Genor Biopharma Holdings (6998 HK)

44
Analysis
Health Care • China
Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.
more
bullish•GoodRx Holdings Inc
•21 Sep 2020 13:38

GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits

GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly...

Share
•17 Sep 2020 16:25

Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters

JHBP (CY) Holdings Ltd also known as Genor Biopharma has filed for an IPO on the Hong Kong Stock Exchange to raise about HK$2.48bn (US$320m). The...

Share
•17 Sep 2020 01:38

JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure

$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...

Logo
530 Views
Share
•15 Sep 2020 09:48

JHBP/Genor (å˜‰å’Œē”Ÿē‰©) Pre-IPO: Thoughts on Valuation

JHBP/Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...

Logo
526 Views
Share
bullish•Ant Group
•13 Sep 2020 09:38

ECM Weekly (13 September 2020) - Ant Group, Joy Spreader, Chindata, Huazhu Secondary, Converge ICT

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. In...

Share
x